MindMed Completes Phase 1 LSD Dosing Study Post published:November 2, 2020 Post category:Press Release
Psychedelic Bulletin: MindMed Raises $28.75m, Entheon Inches Closer to Go-Public, Next Week’s Votes on Decriminalisation Post published:October 30, 2020 Post category:Psychedelic Bulletin
Havn Life Sciences to Support the First Modern Psilocybin Depression Study in Germany with Mind Foundation Post published:October 30, 2020 Post category:Press Release
MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines Post published:October 30, 2020 Post category:Press Release
Cybin Corp Establishes a Firm Foothold in the Psychedelic Sector with Historic CAD$45 Million Raise Post published:October 30, 2020 Post category:Analysis/Editorial
MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™ Post published:October 30, 2020 Post category:Press Release
Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials Post published:October 29, 2020 Post category:Press Release
Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment Post published:October 29, 2020 Post category:Press Release
Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor Post published:October 29, 2020 Post category:Press Release
Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development Post published:October 29, 2020 Post category:Press Release